Form 8-K - Current report:
SEC Accession No. 0001829126-25-005715
Filing Date
2025-08-04
Accepted
2025-08-01 18:48:28
Documents
15
Period of Report
2025-08-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nexalintech_8k.htm   iXBRL 8-K 32779
2 EXHIBIT 99.1 nexalintech_ex99-1.htm EX-99.1 12597
3 GRAPHIC ex99-1_001.jpg GRAPHIC 8742
  Complete submission text file 0001829126-25-005715.txt   272566

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nxl-20250801.xsd EX-101.SCH 3750
5 XBRL DEFINITION FILE nxl-20250801_def.xml EX-101.DEF 26614
6 XBRL LABEL FILE nxl-20250801_lab.xml EX-101.LAB 36724
7 XBRL PRESENTATION FILE nxl-20250801_pre.xml EX-101.PRE 25238
17 EXTRACTED XBRL INSTANCE DOCUMENT nexalintech_8k_htm.xml XML 5832
Mailing Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056
Business Address 1776 YORKTOWN SUITE 550 HOUSTON TX 77056 (832) 260-0222
Nexalin Technology, Inc. (Filer) CIK: 0001527352 (see all company filings)

EIN.: 275566468 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41507 | Film No.: 251177611
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)